INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 114 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2018. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $103,048 | -51.6% | 10,223 | -39.4% | 0.00% | +100.0% |
| Q2 2017 | $213,000 | +20.3% | 16,871 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $177,000 | +14.2% | 16,871 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $155,000 | -22.1% | 16,871 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $199,000 | -8.7% | 16,871 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $218,000 | -19.3% | 16,871 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $270,000 | -44.1% | 16,871 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $483,000 | +0.6% | 16,871 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $480,000 | -18.9% | 16,871 | +2.3% | 0.00% | -25.0% |
| Q2 2015 | $592,000 | +42.0% | 16,492 | +130.1% | 0.00% | +33.3% |
| Q1 2015 | $417,000 | +23.0% | 7,168 | -10.9% | 0.00% | +50.0% |
| Q4 2014 | $339,000 | +25.1% | 8,045 | +15.2% | 0.00% | 0.0% |
| Q3 2014 | $271,000 | +24.3% | 6,983 | -0.0% | 0.00% | 0.0% |
| Q2 2014 | $218,000 | -24.6% | 6,984 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $289,000 | +60.6% | 6,984 | +50.0% | 0.00% | +100.0% |
| Q4 2013 | $180,000 | – | 4,656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
| ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
| Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
| Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
| TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
| Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
| GAM Holding AG | 83,940 | $808,000 | 0.02% |
| SFMG, LLC | 11,994 | $115,000 | 0.02% |
| SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |